| Control (n = 14) | Stroke (n = 60) | P value |
---|---|---|---|
Age | 66.0±1.41 | 71.2±11.8 | 0.001 |
Male sex | 8 (57.1%) | 34 (56.7%) | 0.97 |
Hypertension | 12 (85.7) | 39 (65.0%) | 0.20 |
Diabetes mellitus | 5 (35.7%) | 22 (36.7%) | 0.95 |
Hyperlipidemia | 10 (71.4%) | 33 (55.0%) | 0.37 |
Atrial fibrillation | 5 (35.7%) | 37 (61.7%) | 0.13 |
NfL pg/ml | 9.44 (7.73, 13.0) | 33.3 (19.6, 88.9) | 0.046 |
GFAP pg/mL | 82.9 (55.3, 114.0) | 238.8 (146.0, 330.5) | 0.015 |
Tau pg/mL | 1.62 (1.12, 2.00) | 1.71 (0.97, 2.87) | 0.26 |
UCHL1 pg/mL | 7.30 (4.13, 13.5) | 83.6 (64.8, 107.6) | <0.001 |
Log NfL | 2.33±0.37 | 3.74±1.17 | <0.001 |
Log GFAP | 4.35±0.50 | 5.63±0.97 | <0.001 |
Log Tau | 0.31±0.75 | 0.38±1.12 | 0.61 |
Log UCHL1 | 1.95±0.91 | 4.41±0.40 | <0.001 |